Harmony Biosciences Holdings (HRMY) — Long-term Investment Intensity
Harmony Biosciences Holdings (HRMY) has a Long-term Investment Intensity of 21.5% as of June 2026. Long-term investments of $294.67 Million represent 21.5% of total assets of $1.37 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Harmony Biosciences Holdings asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Harmony Biosciences Holdings Long-term Investment Intensity (2022–2025)
This chart shows how Harmony Biosciences Holdings's Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the intensity stands at 21.5%, reflecting long-term investments of $294.67 Million against total assets of $1.37 Billion USD. For the complete balance sheet picture, see balance sheet size of Harmony Biosciences Holdings.
Annual Long-term Investment Intensity for Harmony Biosciences Holdings (2022–2025)
The table below presents the year-by-year Long-term Investment Intensity for Harmony Biosciences Holdings from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read HRMY total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 8.4% | $107.13 Million | $1.27 Billion | ▼ -2.5 pp |
| 2024 | 10.9% | $108.87 Million | $999.20 Million | ▲ +2.0 pp |
| 2023 | 8.9% | $72.17 Million | $811.45 Million | ▲ +5.5 pp |
| 2022 | 3.3% | $22.57 Million | $673.87 Million | — |